Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 2000

Study Completion Date

September 30, 2000

Conditions
HIV Infections
Interventions
DRUG

Peginterferon alfa-2b

Trial Locations (22)

10003

Beth Israel Med Ctr, New York

19102

MCP Hahnemann Univ, Philadelphia

19107

Philadelphia FIGHT, Philadelphia

20007

Georgetown Univ Med Ctr, Washington D.C.

30339

Piedmont Physicians at Vinings, Atlanta

32206

Duval County Health Department, Jacksonville

32701

IDC Research Initiative, Altamonte Springs

33136

Univ of Miami School of Medicine, Miami

34239

Infectious Diseases Associates, Sarasota

44106

Univ Hosps of Cleveland, Cleveland

55101

Regions Hosp, Saint Paul

60657

TRIAD Health Practice, Chicago

63110

Washington Univ, St Louis

75235

Amelia Ct Clinic, Dallas

77004

Joseph C Gathe, Houston

94705

East Bay AIDS Ctr, Berkeley

200091104

Dupont Circle Physicians Group, Washington D.C.

212011192

Univ of Maryland Institute of Human Virology, Baltimore

02111

New England Med Ctr / Div of Geo Med & Infect Disease, Boston

08103

Southwestern New Jersey AIDS Clinical Trials, Camden

07018

East Orange Veterans Administration Med Ctr, East Orange

009265800

San Juan VAMC, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Schering-Plough

INDUSTRY